Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
| Image |  |
|---|---|
| Description | scientific article published on 9 June 2017 |
| Author/s |
author: Antonio Calles Enriqueta Felip Tania Fleitas Jan H M Schellens Morten Mau-Sorensen Ulrik Lassen |
| Publication date | June 9, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |